DrugPatentWatch Database Preview
Medexus Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for MEDEXUS, and what generic alternatives to MEDEXUS drugs are available?
MEDEXUS has one approved drug.
There is one US patent protecting MEDEXUS drugs.
There are twenty-five patent family members on MEDEXUS drugs in twenty countries.
Summary for Medexus
| International Patents: | 25 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Medexus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-008 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-010 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| Medexus | RASUVO | methotrexate | SOLUTION;SUBCUTANEOUS | 205776-006 | Jul 10, 2014 | RX | Yes | Yes | 8,664,231 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Medexus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Ukraine | 95488 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2008009476 | Start Trial |
| Cyprus | 1111159 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
